Alpha Mark Advisors, LLC Eli Lilly & CO Transaction History

Alpha Mark Advisors, LLC

$290 Million
Q3 2024

A detailed history of Alpha Mark Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 638 shares of LLY stock, worth $506,661. This represents 0.2% of its overall portfolio holdings.

Number of Shares

638

Previous 798 20.05%

Holding current value

$506,661

Previous $722,000 21.75%

% of portfolio

0.2%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $123,542 - $153,603	-160 Reduced 20.05%	638 $565,000
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $211,662 - $265,439	-292 Reduced 26.79%	798 $722,000
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $75,209 - $100,619	-127 Reduced 10.44%	1,090 $848,000
Q4 2023 Jan 19, 2024	SELL	$525.19 - $619.13 $30,986 - $36,528	-59 Reduced 4.62%	1,217 $709,000
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $3,477 - $4,794	-8 Reduced 0.62%	1,276 $685,000
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $5,261 - $7,034	-15 Reduced 1.15%	1,284 $602,000
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $931 - $1,094	3 Added 0.23%	1,299 $446,000
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $64,310 - $74,934	-200 Reduced 13.37%	1,296 $474,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $50,105 - $57,100	-169 Reduced 10.15%	1,496 $484,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $9,755 - $11,454	-35 Reduced 2.06%	1,665 $540,000
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $46,938 - $58,332	-200 Reduced 10.53%	1,700 $487,000
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $24,733 - $30,694	-110 Reduced 5.47%	1,900 $525,000
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $47,644 - $58,632	-215 Reduced 9.66%	2,010 $464,000
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $18,235 - $23,587	-101 Reduced 4.34%	2,225 $511,000
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $24,483 - $31,695	-149 Reduced 6.02%	2,326 $434,000
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $75,014 - $99,262	-575 Reduced 18.85%	2,475 $417,000
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $23,191 - $27,910	-170 Reduced 5.28%	3,050 $501,000
Q1 2020 Apr 24, 2020	BUY	$119.05 - $147.35 $2,381 - $2,947	20 Added 0.63%	3,220 $447,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $26,730 - $33,107	250 Added 8.47%	3,200 $421,000
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $15,377 - $16,727	-144 Reduced 4.65%	2,950 $330,000
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $30,610 - $36,030	275 Added 9.76%	3,094 $401,000
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $51,785 - $58,014	-489 Reduced 14.78%	2,819 $326,000
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $7,418 - $8,514	-98 Reduced 2.88%	3,308 $282,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $35,175 - $41,522	-474 Reduced 12.22%	3,406 $264,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $75,712 - $81,210	-924 Reduced 19.23%	3,880 $328,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $370,244 - $410,934	4,804	4,804 $411,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Account

Alpha Mark Advisors, LLC Eli Lilly & CO Transaction History